Pub Date : 2022-11-01DOI: 10.1177/03000605221138455
Merja K Laine, Hannu Kautiainen, Mika Gissler, Pirjo Pennanen, Johan G Eriksson
Objective: Some drugs have adverse effects on glucose metabolism, but it is unknown whether prescription drugs used prior to conception influence the future risk of gestational diabetes mellitus (GDM). Our study evaluated whether the purchase of prescription drugs 6 months prior to conception was associated with the occurrence of GDM.
Methods: This cohort study enrolled women with a Finnish background who delivered between 2009 and 2015 in the city of Vantaa, Finland (N = 10,455). Data on maternal characteristics and prescription drug purchases were obtained from national health registers. The use of a unique personal identification number enabled us to combine the register data on an individual level.
Results: Six months prior to conception, women who had pregnancies complicated by GDM purchased more prescription drugs than women without GDM (1.38 ± 2.04 vs. 1.11 ± 1.80). The GDM risk was higher in women with higher numbers of prescription purchases and those with more than three deliveries.
Conclusions: Multiparous women who purchase several prescription drugs should be given personalized counseling to prevent GDM.
{"title":"Drug purchases prior to conception and the risk of gestational diabetes mellitus.","authors":"Merja K Laine, Hannu Kautiainen, Mika Gissler, Pirjo Pennanen, Johan G Eriksson","doi":"10.1177/03000605221138455","DOIUrl":"https://doi.org/10.1177/03000605221138455","url":null,"abstract":"<p><strong>Objective: </strong>Some drugs have adverse effects on glucose metabolism, but it is unknown whether prescription drugs used prior to conception influence the future risk of gestational diabetes mellitus (GDM). Our study evaluated whether the purchase of prescription drugs 6 months prior to conception was associated with the occurrence of GDM.</p><p><strong>Methods: </strong>This cohort study enrolled women with a Finnish background who delivered between 2009 and 2015 in the city of Vantaa, Finland (N = 10,455). Data on maternal characteristics and prescription drug purchases were obtained from national health registers. The use of a unique personal identification number enabled us to combine the register data on an individual level.</p><p><strong>Results: </strong>Six months prior to conception, women who had pregnancies complicated by GDM purchased more prescription drugs than women without GDM (1.38 ± 2.04 vs. 1.11 ± 1.80). The GDM risk was higher in women with higher numbers of prescription purchases and those with more than three deliveries.</p><p><strong>Conclusions: </strong>Multiparous women who purchase several prescription drugs should be given personalized counseling to prevent GDM.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221138455"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/ed/10.1177_03000605221138455.PMC9716604.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40491120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221137443
Lerzan Dogan, Aytaj Allahverdiyeva, Mustafa Önel, Sevim Meşe, Esra Saka Ersin, İlkay Anaklı, Zeynep Tuğçe Sarıkaya, Rehile Zengin, Bulent Gucyetmez, Neval Yurtturan Uyar, Perihan Ergin Özcan, Ayse Sesin Kocagöz, Hayriye Kırkoyun Uysal, İbrahim Ozkan Akinci, Ali Ağaçfidan
Objective: Viral load varies during infection and is higher during the initial stages of disease. Given the importance of the intensive care unit (ICU) in the late stages of COVID-19 infection, analyzing cycle threshold values to detect viral load upon ICU admission can be a clinically valuable tool for identifying patients with the highest mortality risk.
Methods: This was a retrospectively designed study. Patients older than 18 years who tested positive for SARS-CoV-2 PCR and had a PaO2/FiO2 ratio <200 were included in the study. The patient population was divided into two groups: survivors and non-survivors.
Results: Two hundred patients were included in the study. In non-survivors, age, relevant ICU admission scores, and procalcitonin levels were significantly higher whereas PaO2/FiO2 ratios and cycle threshold levels were significantly lower than in survivors.
Conclusion: Viral load at ICU admission has significant prognostic value. In combination with age, comorbidities, and severity scores, viral load may assist clinicians in identifying individuals who need more intensive monitoring. Increased awareness may improve outcomes by allowing the more effective monitoring and treatment of patients. More prospective studies are needed to determine how a high viral load worsens disease and how to avoid irreversible results.
{"title":"Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients?","authors":"Lerzan Dogan, Aytaj Allahverdiyeva, Mustafa Önel, Sevim Meşe, Esra Saka Ersin, İlkay Anaklı, Zeynep Tuğçe Sarıkaya, Rehile Zengin, Bulent Gucyetmez, Neval Yurtturan Uyar, Perihan Ergin Özcan, Ayse Sesin Kocagöz, Hayriye Kırkoyun Uysal, İbrahim Ozkan Akinci, Ali Ağaçfidan","doi":"10.1177/03000605221137443","DOIUrl":"https://doi.org/10.1177/03000605221137443","url":null,"abstract":"<p><strong>Objective: </strong>Viral load varies during infection and is higher during the initial stages of disease. Given the importance of the intensive care unit (ICU) in the late stages of COVID-19 infection, analyzing cycle threshold values to detect viral load upon ICU admission can be a clinically valuable tool for identifying patients with the highest mortality risk.</p><p><strong>Methods: </strong>This was a retrospectively designed study. Patients older than 18 years who tested positive for SARS-CoV-2 PCR and had a PaO<sub>2</sub>/FiO<sub>2</sub> ratio <200 were included in the study. The patient population was divided into two groups: survivors and non-survivors.</p><p><strong>Results: </strong>Two hundred patients were included in the study. In non-survivors, age, relevant ICU admission scores, and procalcitonin levels were significantly higher whereas PaO<sub>2</sub>/FiO<sub>2</sub> ratios and cycle threshold levels were significantly lower than in survivors.</p><p><strong>Conclusion: </strong>Viral load at ICU admission has significant prognostic value. In combination with age, comorbidities, and severity scores, viral load may assist clinicians in identifying individuals who need more intensive monitoring. Increased awareness may improve outcomes by allowing the more effective monitoring and treatment of patients. More prospective studies are needed to determine how a high viral load worsens disease and how to avoid irreversible results.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221137443"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/5b/10.1177_03000605221137443.PMC9716617.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40723090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221133988
Jie Ge, Shan-Shan Cao, Xiao-Yu Cao, Meng Tang, Fei Mu, Yi Qiao, Yue Guan, Jing-Wen Wang
Lamotrigine is an antiepileptic drug that can be used to control many types of seizures as a single-agent or an add-on therapy in patients over 2 years of age. In addition to common adverse reactions, this current case report describes a paediatric male patient with a rare side-effect of persistent penile erectile due to lamotrigine. Previous studies have shown that it can improve sexual function in adult male patients. This patient suffered from refractory epilepsy and pneumonia. He had taken a variety of antiepileptic drugs for a long time and developed priapism after the dosage of lamotrigine had been increased. The priapism improved after drug withdrawal and sedation. Further research is needed to elucidate the mechanism of this rare side-effect.
{"title":"Lamotrigine induced priapism in children: case analysis and literature review.","authors":"Jie Ge, Shan-Shan Cao, Xiao-Yu Cao, Meng Tang, Fei Mu, Yi Qiao, Yue Guan, Jing-Wen Wang","doi":"10.1177/03000605221133988","DOIUrl":"https://doi.org/10.1177/03000605221133988","url":null,"abstract":"<p><p>Lamotrigine is an antiepileptic drug that can be used to control many types of seizures as a single-agent or an add-on therapy in patients over 2 years of age. In addition to common adverse reactions, this current case report describes a paediatric male patient with a rare side-effect of persistent penile erectile due to lamotrigine. Previous studies have shown that it can improve sexual function in adult male patients. This patient suffered from refractory epilepsy and pneumonia. He had taken a variety of antiepileptic drugs for a long time and developed priapism after the dosage of lamotrigine had been increased. The priapism improved after drug withdrawal and sedation. Further research is needed to elucidate the mechanism of this rare side-effect.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221133988"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/9f/10.1177_03000605221133988.PMC9703579.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40701897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221138492
Maria Azmerin, Md Saddam Hussain, Md Abdul Aziz, Md Abdul Barek, Mobashera Begum, Niloy Sen, Md Abdur Rahman, Mohammad Shahriar, Saleh Salem Baeesa, Ghulam Md Ashraf, Mohammad Safiqul Islam
Objective: Although the prevalence of autism spectrum disorder (ASD) is increasing, appropriate diagnosis and prevention strategies are still lacking. This case-control study was designed to explore the association between ASD and the rs1867503 and rs9951150 polymorphisms of the TF and TCF4 genes, respectively.
Methods: Ninety-six children with ASD and 118 healthy children were recruited and polymerase chain reaction-restriction fragment length polymorphism technique was applied for genotyping.
Results: The frequencies of the mutant allele G were 48% and 44% for the rs1867503 and rs9951150 polymorphisms, respectively. In our analysis, both TF and TCF4 polymorphisms were associated with an increased risk of developing ASD. AG heterozygotes (OR = 3.18), GG mutant homozygotes (OR = 2.62), AG + GG combined genotypes (OR = 2.98), and G mutant alleles of TF rs1867503 (OR = 1.94) were associated with a significantly elevated risk of ASD. Likewise, AG heterozygotes (OR = 2.92), GG mutant homozygotes (OR = 2.36), AG + GG combined genotypes (OR = 2.72), and G minor alleles of TCF4 rs9951150 (OR = 1.92) were associated with a significantly elevated risk of ASD.
Conclusions: Our results indicate that TF rs1867503 and TCF4 rs9951150 polymorphisms may be strongly associated with the development of ASD in Bangladeshi children.
{"title":"<i>TF</i> and <i>TCF4</i> gene polymorphisms are linked to autism spectrum disorder: a case-control study.","authors":"Maria Azmerin, Md Saddam Hussain, Md Abdul Aziz, Md Abdul Barek, Mobashera Begum, Niloy Sen, Md Abdur Rahman, Mohammad Shahriar, Saleh Salem Baeesa, Ghulam Md Ashraf, Mohammad Safiqul Islam","doi":"10.1177/03000605221138492","DOIUrl":"https://doi.org/10.1177/03000605221138492","url":null,"abstract":"<p><strong>Objective: </strong>Although the prevalence of autism spectrum disorder (ASD) is increasing, appropriate diagnosis and prevention strategies are still lacking. This case-control study was designed to explore the association between ASD and the rs1867503 and rs9951150 polymorphisms of the <i>TF</i> and <i>TCF4</i> genes, respectively.</p><p><strong>Methods: </strong>Ninety-six children with ASD and 118 healthy children were recruited and polymerase chain reaction-restriction fragment length polymorphism technique was applied for genotyping.</p><p><strong>Results: </strong>The frequencies of the mutant allele G were 48% and 44% for the rs1867503 and rs9951150 polymorphisms, respectively. In our analysis, both <i>TF</i> and <i>TCF4</i> polymorphisms were associated with an increased risk of developing ASD. AG heterozygotes (OR = 3.18), GG mutant homozygotes (OR = 2.62), AG + GG combined genotypes (OR = 2.98), and G mutant alleles of <i>TF</i> rs1867503 (OR = 1.94) were associated with a significantly elevated risk of ASD. Likewise, AG heterozygotes (OR = 2.92), GG mutant homozygotes (OR = 2.36), AG + GG combined genotypes (OR = 2.72), and G minor alleles of <i>TCF4</i> rs9951150 (OR = 1.92) were associated with a significantly elevated risk of ASD.</p><p><strong>Conclusions: </strong>Our results indicate that <i>TF</i> rs1867503 and <i>TCF4</i> rs9951150 polymorphisms may be strongly associated with the development of ASD in Bangladeshi children.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221138492"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/48/10.1177_03000605221138492.PMC9716618.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40710311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221132463
Aysun Damci, Janneke G J Hoeijmakers, Jeroen de Jong, Catharina G Faber, Maria A C de Mooij, Jeanine A M C F Verbunt, Mariëlle E J B Goossens
Objective: Small fiber neuropathy (SFN) is characterized by chronic neuropathic pain and autonomic dysfunction. Currently, symptomatic pharmacological treatment is often insufficient and frequently causes side effects. SFN patients have a reduced quality of life. However, little is known regarding whether psycho-social variables influence the development and maintenance of SFN-related disability and complaints. Additional knowledge may have consequences for the treatment of SFN. For example, factors such as thinking, feeling, and behavior are known to play roles in other chronic pain conditions. The aim of this study was to obtain further in-depth information about the experience of living with SFN and related chronic pain.
Methods: Fifteen participants with idiopathic SFN participated in a prospective, semi-structured, qualitative, focus group interview study. The focus groups were audio-recorded, transcribed, and analyzed cyclically after each interview.
Results: The following main themes were identified: "pain appraisal", "coping", "social, work, and health environment", and "change in identity". Catastrophic thoughts and negative emotions were observed. Living with SFN resulted in daily limitations and reduced quality of life.
Conclusions: Given the results, it can be concluded that an optimal treatment should include biological, psychological, and social components.
{"title":"Living with small fiber neuropathy: insights from qualitative focus group interviews.","authors":"Aysun Damci, Janneke G J Hoeijmakers, Jeroen de Jong, Catharina G Faber, Maria A C de Mooij, Jeanine A M C F Verbunt, Mariëlle E J B Goossens","doi":"10.1177/03000605221132463","DOIUrl":"https://doi.org/10.1177/03000605221132463","url":null,"abstract":"<p><strong>Objective: </strong>Small fiber neuropathy (SFN) is characterized by chronic neuropathic pain and autonomic dysfunction. Currently, symptomatic pharmacological treatment is often insufficient and frequently causes side effects. SFN patients have a reduced quality of life. However, little is known regarding whether psycho-social variables influence the development and maintenance of SFN-related disability and complaints. Additional knowledge may have consequences for the treatment of SFN. For example, factors such as thinking, feeling, and behavior are known to play roles in other chronic pain conditions. The aim of this study was to obtain further in-depth information about the experience of living with SFN and related chronic pain.</p><p><strong>Methods: </strong>Fifteen participants with idiopathic SFN participated in a prospective, semi-structured, qualitative, focus group interview study. The focus groups were audio-recorded, transcribed, and analyzed cyclically after each interview.</p><p><strong>Results: </strong>The following main themes were identified: \"pain appraisal\", \"coping\", \"social, work, and health environment\", and \"change in identity\". Catastrophic thoughts and negative emotions were observed. Living with SFN resulted in daily limitations and reduced quality of life.</p><p><strong>Conclusions: </strong>Given the results, it can be concluded that an optimal treatment should include biological, psychological, and social components.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221132463"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/f6/10.1177_03000605221132463.PMC9663626.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40465100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To determine whether a relationship exists between sarcopenia, including its individual components (muscle mass, muscle strength and gait speed), and mild-to-moderate chronic kidney disease (CKD) in Chinese older adults.
Methods: This cross-sectional study comprised participants aged ≥60 years from Tianjin and Shanghai, China, who joined a national free physical examination program between 2014 and 2019, and consented to study inclusion. Sarcopenia was defined according to the Asian Working Group for Sarcopenia (2019 version). Mild-to-moderate CKD was defined as estimated glomerular filtration rate (eGFR) between 45 ml/min/1.73 m2 and 60 ml/min/1.73 m2.
Results: A total of 1627 participants were included (mean age, 69.32 ± 6.17 years; 43.8% male). Sarcopenia was significantly associated with mild-to-moderate CKD in men but not women. Among three physical performance components, slow gait speed (odds ratio 1.89, 95% confidence interval 1.38, 2.58) was associated with mild-to-moderate CKD in both men and women after adjusting for all other variables.
Conclusions: Sarcopenia was closely associated with mild-to-moderate CKD in older men, and slow gait speed was related to mild-to-moderate CKD in men and women. These findings may help guide better diagnosis and management of CKD in the context of slow gait speed, and facilitate earlier CKD detection and appropriate intervention in older adults.
{"title":"Sarcopenia is associated with mild-to-moderate chronic kidney disease in Chinese community-dwelling older men but not in women.","authors":"Xiaoyu Chen, Xiaoyan Zhu, Peipei Han, Yuanyuan Zhang, Mian He, Yuhui Zhang, Jinghuan Liu, Jiawei Tang, Yisong Zhang, Yaqing Zheng, Ziwei Zhang, Ming Li, Qi Guo","doi":"10.1177/03000605221136683","DOIUrl":"https://doi.org/10.1177/03000605221136683","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether a relationship exists between sarcopenia, including its individual components (muscle mass, muscle strength and gait speed), and mild-to-moderate chronic kidney disease (CKD) in Chinese older adults.</p><p><strong>Methods: </strong>This cross-sectional study comprised participants aged ≥60 years from Tianjin and Shanghai, China, who joined a national free physical examination program between 2014 and 2019, and consented to study inclusion. Sarcopenia was defined according to the Asian Working Group for Sarcopenia (2019 version). Mild-to-moderate CKD was defined as estimated glomerular filtration rate (eGFR) between 45 ml/min/1.73 m<sup>2</sup> and 60 ml/min/1.73 m<sup>2</sup>.</p><p><strong>Results: </strong>A total of 1627 participants were included (mean age, 69.32 ± 6.17 years; 43.8% male). Sarcopenia was significantly associated with mild-to-moderate CKD in men but not women. Among three physical performance components, slow gait speed (odds ratio 1.89, 95% confidence interval 1.38, 2.58) was associated with mild-to-moderate CKD in both men and women after adjusting for all other variables.</p><p><strong>Conclusions: </strong>Sarcopenia was closely associated with mild-to-moderate CKD in older men, and slow gait speed was related to mild-to-moderate CKD in men and women. These findings may help guide better diagnosis and management of CKD in the context of slow gait speed, and facilitate earlier CKD detection and appropriate intervention in older adults.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221136683"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/d0/10.1177_03000605221136683.PMC9716608.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221138843
Valentina Barbieri, Luca Scarabel, Laura Bertella, Federica Scarpina, Nicola Schiavone, Laura Perucca, Paolo Rossi
Objective: Functional impairments after coronavirus disease 2019 (COVID-19) constitute a major concern in rehabilitative settings; however, evidence assessing the efficacy of rehabilitation programs is lacking. The aim of this study was to verify the clinical characteristics that may represent useful predictors of the short-term effectiveness of multidisciplinary rehabilitation.
Methods: In this real-practice retrospective pre-post intervention cohort study, the short-term effectiveness of a multidisciplinary patient-tailored rehabilitation program was assessed through normalized variations in the Functional Independence Measure in post-acute care patients who had overcome severe COVID-19. Biochemical markers, motor and nutritional characteristics, and the level of comorbidity were evaluated as predictors of functional outcome. Length of stay in the rehabilitation ward was also considered.
Results: Following rehabilitation, all participants (n = 53) reported a significant decrease in the level of disability in both motor and cognitive functioning. However, neither motor and nutritional characteristics nor comorbidities played a significant role in predicting the overall positive change registered after rehabilitation.
Conclusions: The results support the existing sparse evidence addressing the importance of an early rehabilitation program for patients who received intensive care and post-acute care due to severe COVID-19.
{"title":"Evaluation of the predictive factors of the short-term effects of a multidisciplinary rehabilitation in COVID-19 survivors.","authors":"Valentina Barbieri, Luca Scarabel, Laura Bertella, Federica Scarpina, Nicola Schiavone, Laura Perucca, Paolo Rossi","doi":"10.1177/03000605221138843","DOIUrl":"https://doi.org/10.1177/03000605221138843","url":null,"abstract":"<p><strong>Objective: </strong>Functional impairments after coronavirus disease 2019 (COVID-19) constitute a major concern in rehabilitative settings; however, evidence assessing the efficacy of rehabilitation programs is lacking. The aim of this study was to verify the clinical characteristics that may represent useful predictors of the short-term effectiveness of multidisciplinary rehabilitation.</p><p><strong>Methods: </strong>In this real-practice retrospective pre-post intervention cohort study, the short-term effectiveness of a multidisciplinary patient-tailored rehabilitation program was assessed through normalized variations in the Functional Independence Measure in post-acute care patients who had overcome severe COVID-19. Biochemical markers, motor and nutritional characteristics, and the level of comorbidity were evaluated as predictors of functional outcome. Length of stay in the rehabilitation ward was also considered.</p><p><strong>Results: </strong>Following rehabilitation, all participants (<i>n</i> = 53) reported a significant decrease in the level of disability in both motor and cognitive functioning. However, neither motor and nutritional characteristics nor comorbidities played a significant role in predicting the overall positive change registered after rehabilitation.</p><p><strong>Conclusions: </strong>The results support the existing sparse evidence addressing the importance of an early rehabilitation program for patients who received intensive care and post-acute care due to severe COVID-19.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221138843"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d5/f7/10.1177_03000605221138843.PMC9716619.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present the cases of two otherwise healthy adults, one with meningitis and another with a subdural abscess, with both conditions attributable to Streptococcus pneumoniae. A 31-year-old man was admitted with a 3-day history of fever, headache, and vomiting. Physical examination revealed intermittent confusion, irritability, and neck stiffness. Cerebrospinal fluid (CSF) culture was positive for S. pneumoniae. Contrast-enhanced magnetic resonance imaging (C-MRI) revealed multiple small lesions on the bilateral frontal lobes. Intravenous ceftriaxone and vancomycin were administered, followed by intravenous moxifloxacin. His symptoms resolved within 3 months. Additionally, a 66-year-old man was admitted for acute fever with confusion, abnormal behavior, and a recent history of acute respiratory infection. Physical examination revealed confusion, neck stiffness, and a positive right Babinski sign. CSF metagenomic analysis detected S. pneumoniae. C-MRI disclosed left occipitotemporal meningoencephalitis with subdural abscesses. Intravenous ceftriaxone was administered for 3 weeks. His condition gradually improved, with resorbed lesions detected on repeat MRI. This study expanded the clinical and imaging spectra of S. pneumoniae meningitis. In healthy adults, S. pneumoniae can invade the brain, but subdural abscess is a rare neuroimaging manifestation. Early diagnosis of S. pneumoniae meningitis by high-throughput sequencing and flexible treatment strategies are necessary for satisfactory outcomes.
{"title":"Healthy adults with <i>Streptococcus pneumoniae</i> meningitis and <i>Streptococcus pneumoniae</i> subdural abscess: two case reports and a literature review.","authors":"Fanxin Kong, Liling Li, Daxue Zhang, Baorong Lian, Xudong Liu, Shuqun Ren, Yu Zhang, Liming Cao","doi":"10.1177/03000605221137470","DOIUrl":"https://doi.org/10.1177/03000605221137470","url":null,"abstract":"<p><p>We present the cases of two otherwise healthy adults, one with meningitis and another with a subdural abscess, with both conditions attributable to <i>Streptococcus pneumoniae</i>. A 31-year-old man was admitted with a 3-day history of fever, headache, and vomiting. Physical examination revealed intermittent confusion, irritability, and neck stiffness. Cerebrospinal fluid (CSF) culture was positive for <i>S. pneumoniae</i>. Contrast-enhanced magnetic resonance imaging (C-MRI) revealed multiple small lesions on the bilateral frontal lobes. Intravenous ceftriaxone and vancomycin were administered, followed by intravenous moxifloxacin. His symptoms resolved within 3 months. Additionally, a 66-year-old man was admitted for acute fever with confusion, abnormal behavior, and a recent history of acute respiratory infection. Physical examination revealed confusion, neck stiffness, and a positive right Babinski sign. CSF metagenomic analysis detected <i>S. pneumoniae</i>. C-MRI disclosed left occipitotemporal meningoencephalitis with subdural abscesses. Intravenous ceftriaxone was administered for 3 weeks. His condition gradually improved, with resorbed lesions detected on repeat MRI. This study expanded the clinical and imaging spectra of <i>S. pneumoniae</i> meningitis. In healthy adults, <i>S. pneumoniae</i> can invade the brain, but subdural abscess is a rare neuroimaging manifestation. Early diagnosis of <i>S. pneumoniae</i> meningitis by high-throughput sequencing and flexible treatment strategies are necessary for satisfactory outcomes.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221137470"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/e2/10.1177_03000605221137470.PMC9679341.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40475265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221137475
Alberto Melchor-López, Juan Antonio Suárez-Cuenca, Diana Zaineff Banderas-Lares, Gustavo De la Peña-Sosa, Moisés Salamanca-García, Eduardo Vera-Gómez, Alejandro Hernández-Patricio, Juan Ariel Gutiérrez-Buendía, Carlos Ramiro Zamora-Alemán, Sofía Lizeth Alcaráz-Estrada, Moisés Ortiz-Fernández, Jesús Montoya-Ramírez, Omar Felipe Gaytán-Fuentes, Mónica Escamilla-Tilch, Juan Antonio Pineda-Juárez, Mario Antonio Téllez-González, Martha Eunice Rodríguez-Arellano, Alejandra Contreras-Ramos, Rolando Efraín Hernández-Muñoz, José Gutiérrez-Salinas, Silvia García, Paul Mondragón-Terán
Objectives: To determine whether metabolic phenotype is associated with the change in carotid intima-media thickness (CIMT) in patients undergoing bariatric /metabolic surgery (BMS).
Methods: We performed a case-control study of BMS candidates who had metabolically unhealthy obesity (MUO) or metabolically healthy obesity (MHO). We measured the change in CIMT during the 9 months following BMS. The plasma tumor necrosis factor-α, interleukin-1β, adiponectin, leptin, nitric oxide (NO), vascular endothelial growth factor A (VEGF-A), and malondialdehyde concentrations were determined, adipocyte area was measured histologically, and adipose tissue area was estimated using computed tomography.
Results: Fifty-six patients (mean age 44.5 years, mean body mass index 44.9 kg/m2, 53% women, and 53% had MUO) were studied. Nine months following BMS, the MUO phenotype was not associated with a significant reduction in CIMT, and that of the MHO group was larger. In addition, fewer participants achieved a 10% reduction in CIMT in the MUO group. A CIMT reduction was associated with lower VEGF-A and NO in the MUO group, while that in the MHO group was associated with a higher NO concentration.
Conclusion: The metabolic phenotype of patients may influence their change in CIMT following BMS, probably through circulating vasodilatory and pro-inflammatory molecules.
{"title":"The metabolic phenotype of the patient influences the reduction in carotid intima-media thickness achieved following metabolic surgery.","authors":"Alberto Melchor-López, Juan Antonio Suárez-Cuenca, Diana Zaineff Banderas-Lares, Gustavo De la Peña-Sosa, Moisés Salamanca-García, Eduardo Vera-Gómez, Alejandro Hernández-Patricio, Juan Ariel Gutiérrez-Buendía, Carlos Ramiro Zamora-Alemán, Sofía Lizeth Alcaráz-Estrada, Moisés Ortiz-Fernández, Jesús Montoya-Ramírez, Omar Felipe Gaytán-Fuentes, Mónica Escamilla-Tilch, Juan Antonio Pineda-Juárez, Mario Antonio Téllez-González, Martha Eunice Rodríguez-Arellano, Alejandra Contreras-Ramos, Rolando Efraín Hernández-Muñoz, José Gutiérrez-Salinas, Silvia García, Paul Mondragón-Terán","doi":"10.1177/03000605221137475","DOIUrl":"https://doi.org/10.1177/03000605221137475","url":null,"abstract":"<p><strong>Objectives: </strong>To determine whether metabolic phenotype is associated with the change in carotid intima-media thickness (CIMT) in patients undergoing bariatric /metabolic surgery (BMS).</p><p><strong>Methods: </strong>We performed a case-control study of BMS candidates who had metabolically unhealthy obesity (MUO) or metabolically healthy obesity (MHO). We measured the change in CIMT during the 9 months following BMS. The plasma tumor necrosis factor-α, interleukin-1β, adiponectin, leptin, nitric oxide (NO), vascular endothelial growth factor A (VEGF-A), and malondialdehyde concentrations were determined, adipocyte area was measured histologically, and adipose tissue area was estimated using computed tomography.</p><p><strong>Results: </strong>Fifty-six patients (mean age 44.5 years, mean body mass index 44.9 kg/m<sup>2</sup>, 53% women, and 53% had MUO) were studied. Nine months following BMS, the MUO phenotype was not associated with a significant reduction in CIMT, and that of the MHO group was larger. In addition, fewer participants achieved a 10% reduction in CIMT in the MUO group. A CIMT reduction was associated with lower VEGF-A and NO in the MUO group, while that in the MHO group was associated with a higher NO concentration.</p><p><strong>Conclusion: </strong>The metabolic phenotype of patients may influence their change in CIMT following BMS, probably through circulating vasodilatory and pro-inflammatory molecules.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221137475"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/09/10.1177_03000605221137475.PMC9709181.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/03000605221133655
Jun Kang, Jieun Lee, Ahwon Lee, Youn Soo Lee
Objective: Homologous recombination deficiency (HRD) is the main mechanism of tumorigenesis in some cancers. HRD causes abnormal double-strand break repair, resulting in genomic scars. Some scoring HRD tests have been approved as companion diagnostics of polyadenosine diphosphate-ribose polymerase (PARP) inhibitor treatment. This study aimed to build an HRD prediction model using gene expression data from various cancer types.
Methods: The cancer genome atlas data were used for HRD prediction modeling. A total of 10,567 cases of 33 cancer types were included, and expression data from 5128 out of 20,502 genes were included as predictors. A penalized logistic regression model was chosen as a modeling technique.
Results: The area under the curve of the receiver operating characteristic curve of HRD status prediction was 0.98 for the training set and 0.93 for the test set. The accuracy of HRD status prediction was 0.93 for the training set and 0.88 for the test set.
Conclusions: Our study suggests that the HRD prediction model based on penalized logistic regression using gene expression data can be used to select patients for treatment with PARP inhibitors.
{"title":"Prediction of homologous recombination deficiency from cancer gene expression data.","authors":"Jun Kang, Jieun Lee, Ahwon Lee, Youn Soo Lee","doi":"10.1177/03000605221133655","DOIUrl":"https://doi.org/10.1177/03000605221133655","url":null,"abstract":"<p><strong>Objective: </strong>Homologous recombination deficiency (HRD) is the main mechanism of tumorigenesis in some cancers. HRD causes abnormal double-strand break repair, resulting in genomic scars. Some scoring HRD tests have been approved as companion diagnostics of polyadenosine diphosphate-ribose polymerase (PARP) inhibitor treatment. This study aimed to build an HRD prediction model using gene expression data from various cancer types.</p><p><strong>Methods: </strong>The cancer genome atlas data were used for HRD prediction modeling. A total of 10,567 cases of 33 cancer types were included, and expression data from 5128 out of 20,502 genes were included as predictors. A penalized logistic regression model was chosen as a modeling technique.</p><p><strong>Results: </strong>The area under the curve of the receiver operating characteristic curve of HRD status prediction was 0.98 for the training set and 0.93 for the test set. The accuracy of HRD status prediction was 0.93 for the training set and 0.88 for the test set.</p><p><strong>Conclusions: </strong>Our study suggests that the HRD prediction model based on penalized logistic regression using gene expression data can be used to select patients for treatment with PARP inhibitors.</p>","PeriodicalId":245557,"journal":{"name":"The Journal of International Medical Research","volume":" ","pages":"3000605221133655"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/ed/10.1177_03000605221133655.PMC9676333.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40686715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}